Cigna Stock Forecast for 2022 - 2025 - 2030
Updated on 05/24/2022
Given the average yearlong price target of $299.00 provided by six prominent analysts over the past few months, there is a potential upside of approximately 12.85% from the last closing price in May, 2022 for Cigna's stock if it is reached. This estimation is based on a high estimate of $330.00 and a low estimate of $190.00. If you are interested in CI stock, you should also look at its competitors.
12.85% Upside
Cigna Fair Value Forecast for 2022 - 2025 - 2030
In the past three years, Cigna's Fair Value has grown by 43.95%, rising from $173.63 to $249.94. For the next year, analysts predict that Fair Value will reach $274.60 – an increase of 9.87%. Over the next nine years, experts believe that CI's Fair Value will grow at a rate of 141.69%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| BRK.A Stock Forecast | Berkshire Hathaway | Outperform |
5
|
$463.61k | $556.70k | 20.79% | 1 |
| UNH Stock Forecast | UnitedHealth Group | Outperform |
7
|
$497.56 | $526.47 | 18.88% | 6 |
| JPM Stock Forecast | JPMorgan Chase | Outperform |
6
|
$126.36 | $163.59 | 19.9% | 10 |
| WMT Stock Forecast | Walmart | Outperform |
6
|
$124.13 | $168.96 | 25.67% | 17 |
| WFC Stock Forecast | Wells Fargo & | Outperform |
6
|
$43.29 | $59.57 | 38.6% | 8 |
Cigna Revenue Forecast for 2022 - 2025 - 2030
In the past three years, Cigna's Revenue has grown by 258.82%, rising from $48.57B to $174.27B. For the next year, analysts predict that Revenue will reach $179.07B – an increase of 2.75%. Over the next nine years, experts believe that CI's Revenue will grow at a rate of 58.93%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| CVS Stock Forecast | CVS Health | Outperform |
6
|
$96.45 | $118.09 | 24.42% | 17 |
| ANTM Stock Forecast | Anthem | Outperform |
5
|
$505.29 | $434.91 | 13.8% | 8 |
| BLK Stock Forecast | BlackRock | Outperform |
8
|
$618.35 | $1.01k | 40.94% | 14 |
Cigna Dividend per Share Forecast for 2022 - 2025 - 2030
In the last three years, Cigna's DPS has seen significant growth, surging from $0.04 to $4.00 – an increase of 9900%. In the next year, analysts predict that DPS will jump to $4.24 – up 6% from the current level. Looking ahead to nine years, experts forecast that DPS will grow by 108.87%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| ALV Stock Forecast | Allianz | Outperform |
6
|
197.86€ | 249.88€ | 26.35% | 5 |
| USB Stock Forecast | U.S. Bancorp | Outperform |
6
|
$51.04 | $61.18 | 17.55% | 15 |
| ZURN Stock Forecast | Zurich Insurance Group | Outperform |
4
|
CHF432.10 | CHF431.40 | 16.87% | 7 |
Cigna Free Cash Flow Forecast for 2022 - 2025 - 2030
Cigna's Free Cash Flow has seen astonishing growth in the last three years, going from $3.24B to $6.04B – a gain of 86.21% In the next year, analysts believe that Free Cash Flow will reach a reasonable $7.05B – an increase of 16.75% For the next nine years, the forecast is for Free Cash Flow to grow by 33.86%
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| CS Stock Forecast | AXA | Outperform |
7
|
23.12€ | 26.51€ | 31.06% | 11 |
| HUM Stock Forecast | Humana | Outperform |
6
|
$440.42 | $480.18 | 13.76% | 11 |
| CNC Stock Forecast | Centene | Outperform |
8
|
$87.21 | $92.50 | 10.08% | 6 |
Cigna Net Income Forecast for 2022 - 2025 - 2030
In the past three years, Cigna's Net Income has seen a significant increase, rising from $2.64B to $5.37B. This represents a growth of 103.45%. Analysts predict that Cigna's Net Income will increase moderately in the upcoming year, reaching $7.02B. This would represent an increase of 30.81%. Over the next nine years, experts predict that Cigna's Net Income will grow at a rate of 133.51%
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| MCK Stock Forecast | McKesson | Outperform |
4
|
$328.80 | $324.69 | 12.53% | 6 |
| AIG Stock Forecast | American International Group | Outperform |
7
|
$56.51 | $65.43 | 22.1% | 11 |
| KR Stock Forecast | The Kroger | Hold |
6
|
$51.51 | $54.48 | 3.86% | 2 |
Cigna EBITDA Forecast for 2022 - 2025 - 2030
In three years, EBITDA for Cigna has grown by a whopping 94.2%, going from $5.23B to $10.15B. In the coming year, analysts are expecting a moderate increase in EBITDA, predicting it will reach $11.40B – an increase of 12.32%. Over the next nine years, experts anticipate that EBITDA growth for Cigna will be 142.3%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| AFL Stock Forecast | Aflac | Hold |
8
|
$57.08 | $62.77 | 7.74% | 6 |
| WBA Stock Forecast | Walgreens Boots Alliance | Hold |
5
|
$42.08 | $49.19 | 16.44% | 5 |
| MUV2 Stock Forecast | Münchener Rückversicherungs-... | Outperform |
5
|
221.40€ | 276.04€ | 24.21% | 10 |
Cigna EBIT Forecast for 2022 - 2025 - 2030
Cigna's EBIT has seen major growth over the last three years, jumping from $4.87B to $8.35B – an increase of 71.43%. 9.00 analysts predict Cigna's EBIT will decrease by 0.92% in the next year, reaching only $15.07B. For the next nine years, the forecast is for EBIT to grow by 80.47%
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| G Stock Forecast | Assicurazioni Generali S.p.A. | Outperform |
5
|
18.00€ | 17.63€ | 11.11% | 8 |
| AMP Stock Forecast | Ameriprise Financial | Outperform |
0
|
$260.63 | $348.80 | 32.37% | 0 |
| 601601 Stock Forecast | China Pacific Insurance (Group... | Outperform |
5
|
¥21.15 | ¥35.13 | 30.02% | 0 |
Cigna EPS Price Prediction Forecast for 2022 - 2025 - 2030
In the past three years, Cigna's EPS has grown by 43.95%, rising from $14.22 to $20.47. For the next year, analysts predict that EPS will reach $22.49 – an increase of 9.87%. Over the next nine years, experts believe that CI's EPS will grow at a rate of 141.69%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| TROW Stock Forecast | T. Rowe Price Group | Hold |
9
|
$120.34 | $141.09 | 14.68% | 7 |
| SREN Stock Forecast | Swiss Re | Hold |
0
|
CHF99.20 | CHF100.88 | -0.51% | 4 |
| HIG Stock Forecast | The Hartford Financial Service... | Outperform |
7
|
$68.95 | $82.53 | 21.83% | 16 |